BARBATO, EMANUELE
 Distribuzione geografica
Continente #
NA - Nord America 4.074
AS - Asia 1.477
EU - Europa 1.198
AF - Africa 67
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.825
Nazione #
US - Stati Uniti d'America 3.896
SG - Singapore 843
CN - Cina 523
IT - Italia 399
NL - Olanda 211
IE - Irlanda 207
CA - Canada 176
FI - Finlandia 173
DE - Germania 70
VN - Vietnam 57
CI - Costa d'Avorio 56
GB - Regno Unito 36
UA - Ucraina 36
SE - Svezia 24
IN - India 18
HK - Hong Kong 10
JP - Giappone 8
RU - Federazione Russa 8
BE - Belgio 6
BY - Bielorussia 5
CH - Svizzera 5
IR - Iran 5
NG - Nigeria 5
FR - Francia 4
GR - Grecia 4
KE - Kenya 4
CO - Colombia 3
EU - Europa 3
OM - Oman 3
PL - Polonia 3
TW - Taiwan 3
BR - Brasile 2
CY - Cipro 2
EG - Egitto 2
ES - Italia 2
KR - Corea 2
AR - Argentina 1
AZ - Azerbaigian 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GT - Guatemala 1
ID - Indonesia 1
IL - Israele 1
MX - Messico 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
Totale 6.825
Città #
Chandler 741
Singapore 659
Millbury 283
Ashburn 236
Des Moines 231
Princeton 230
Boston 226
Nanjing 208
Amsterdam 194
Santa Clara 174
Ottawa 172
Naples 111
Lawrence 98
Wilmington 84
Beijing 59
Dong Ket 56
Nanchang 50
Napoli 45
Shenyang 43
Hebei 42
Jiaxing 37
Lappeenranta 35
Jacksonville 28
Washington 20
Fairfield 19
Redwood City 19
Changsha 18
Dublin 18
Norwalk 18
Seattle 17
Houston 15
Tianjin 14
Woodbridge 13
Augusta 11
Taurianova 11
Pune 10
Rome 10
Munich 9
Hong Kong 8
Montecchio Emilia 7
San Mateo 7
Catania 5
Dallas 5
Edinburgh 5
Kronberg 5
Leawood 5
Milan 5
Minsk 5
Redmond 5
Duncan 4
Fort Worth 4
Los Angeles 4
Moscow 4
New York 4
Orange 4
San Giuseppe Vesuviano 4
Shanghai 4
Ann Arbor 3
Athens 3
Brussels 3
Esslingen am Neckar 3
Frankfurt am Main 3
Fremont 3
Genoa 3
Gragnano 3
Gurgaon 3
Hangzhou 3
Lausanne 3
Muscat 3
Nairobi 3
San Felice A Cancello 3
Santiago de Cali 3
Trecase 3
Umeda 3
Ardabil 2
Aurisina Cave 2
Boardman 2
Cairo 2
Caivano 2
Cambridge 2
Castelli Calepio 2
Eboli 2
Eindhoven 2
Falls Church 2
Florence 2
Helsinki 2
Limassol 2
London 2
Marseille 2
Nizhniy Novgorod 2
Okayama 2
Prineville 2
Putignano 2
Sale Marasino 2
Sant'anastasia 2
Sinalunga 2
Sorrento 2
Tainan City 2
Taranto 2
Toronto 2
Totale 4.461
Nome #
ST-elevation myocardial infarction and multivessel disease: predictors of non-culprit lesion revascularization 49
ADDED Index or percentage diameter of residual coronary stenosis to risk-stratify patients presenting with STEMI 49
Epidemiology, Pathophysiology, Diagnosis and Management of Chronic Right-Sided Heart Failure and Tricuspid Regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC 47
Development of Left Ventricular Hypertrophy in Treated Hypertensive Outpatients 47
Progression of atherosclerotic carotid plaque in hypertensive patients: the Campania-Salute Network 45
Determinants of aortic root dilatation over time in patients with essential hypertension: The Campania Salute Network 45
Drug-Eluting Stent Implantation. Technique Matters, More Than Ever**Editorials published in JACC: Cardiovascular Interventions reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Interventions or the American College of Cardiology 44
Left Ventricular Mass in Hypertrophic Cardiomyopathy Assessed by 2D-Echocardiography: Validation with Magnetic Resonance Imaging 44
Insulin enhances endothelial alpha2-adrenergic vasorelaxation by a pertussis toxin mechanism. 43
Fractional flow reserve in patients with reduced ejection fraction 43
Development of LV hypertrophy in treated hypertensive patients: the Campania-Salute Network (CSN) 42
Assessment of carotid cross-sectional area in hypertensive patients: phenotyping and prognostic validation in The Campania Salute Network 40
CARDIAC BETA ARK1 UPREGULATION INDUCED BY CHRONIC SALT DEPRIVATION IN RATS 39
Advances in induced pluripotent stem cells, genomics, biomarkers, and antiplatelet therapy highlights of the year in JCTR 2013. 39
?2A-Adrenergic Receptor Polymorphism Potentiates Platelet Reactivity in Patients With Stable Coronary Artery Disease Carrying the Cytochrome P450 2C19*2 Genetic Variant. 39
Thrombus aspiration in primary percutaneous coronary intervention in high-risk patients with ST-elevation myocardial infarction: A real-world registry 38
Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial 38
Aortic valve replacement improves survival in severe aortic stenosis with gradient-area mismatch 38
Effects of nitrendipine on plasma levels of insulin and glucose in patients with essential hypertension 37
Adrenergic receptor polymorphisms and platelet reactivity after treatment with dual antiplatelet therapy with aspirin and clopidogrel in acute coronary syndrome 37
Role of β2 adrenergic receptors in human atherosclerotic coronary arteries 37
Genetically Determined Platelet Reactivity and Related Clinical Implications 37
Diabetes does not impact the diagnostic performance of contrast-based fractional flow reserve: insights from the CONTRAST study 37
Agreement of the Resting Distal to Aortic Coronary Pressure With the Instantaneous Wave-Free Ratio 37
Severity of Coronary Atherosclerosis and Risk of Diabetes Mellitus 37
2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes 37
Insulin Resistance Predicts Severity of Coronary Atherosclerotic Disease in Non-Diabetic Patients 37
Stress-Induced Hyperglycaemia in Non-Diabetic Patients with Acute Coronary Syndrome: From Molecular Mechanisms to New Therapeutic Perspectives 37
Insulin modulation of an endothelial nitric oxide component present in the alfa2-and beta-adrenergic responses in human forearm 36
Validation of coronary flow reserve measurements by thermodilution in clinical practice 36
Direct Stenting for Stable Angina Pectoris Is Associated With Reduced Periprocedural Microcirculatory Injury Compared With Stenting After Pre-Dilation 35
Assessment of renal flow and flow reserve in humans 35
The STIB score: a simple clinical test to predict clopidogrel resistance 35
2017 ESC/EACTS Guidelines for the management of valvular heart disease 35
Coronary lesion progression as assessed by fractional flow reserve (FFR) and angiography 35
Characteristics and Outcomes of Patients Presenting With hypertensive urgency in the Office Setting: The Campania Salute Network 35
Autocrine bradykinin release promotes ischemic preconditioning-induced cytoprotection in bovine aortic endothelial cells 35
Fractional flow reserve-guided versus angiography-guided coronary artery bypass graft surgery. 34
Response to letter regarding article, "revascularization decisions in patients with stable angina and intermediate lesions: Results of the international survey on interventional strategy" 34
Are we ready for a new paradigm shift in percutaneous revascularization of chronically occluded vessels with well-developed collaterals?: From leaving 'Em All to stenting 'Em All 34
Unrecognized anomalous left circumflex coronary artery arising from right sinus of Valsalva: a source of perioperative complication 34
Fractional Flow Reserve-Guided Revascularization in Patients With Aortic Stenosis 34
Effects of Prasugrel Versus Clopidogrel on Coronary Microvascular Function in Patients Undergoing Elective PCI 34
Fractional flow reserve to guide and to assess coronary artery bypass grafting 34
Insulin Resistance and Vitamin D Deficiency: A Link Beyond the Appearances 34
ACEF and clinical SYNTAX score in the risk stratification of patients with heavily calcified coronary stenosis undergoing rotational atherectomy with stent implantation. 33
Mapping interventional cardiology in Europe: proceedings of the 3rd Summit of the European Association of Percutaneous Cardiovascular Interventions 33
Thr164Ile polymorphism of beta2-adrenergic receptor negatively modulates cardiac contractility: implications for prognosis in patients with idiopathic dilated cardiomyopathy 33
A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with Coronary Artery Disease) trial. 32
A first-in-man clinical evaluation of Ultimaster, a new drug-eluting coronary stent system: CENTURY study. 32
The FAME study [Lo studio FAME] 32
European expert consensus on rotational atherectomy 32
Relation of Endothelial Function to Residual Platelet Reactivity After Clopidogrel in Patients With Stable Angina Pectoris Undergoing Percutaneous Coronary Intervention 32
Long-term clinical outcome after fractional flow reserve-guided treatment in patients with angiographically equivocal left main coronary artery stenosis 32
Mid-term outcomes after percutaneous interventions in coronary bifurcations 32
10-Year Survival After FFR-Guided Strategy in Isolated Proximal Left Anterior Descending Coronary Stenosis 32
Biomarkers of vulnerable plaque: The missing link with ischemia 31
Review and Updates in Regenerative and Personalized Medicine, Preclinical Animal Models, and Clinical Care in Cardiovascular Medicine 31
Intracoronary Adenosine: Dose-Response Relationship With Hyperemia 31
Impact of Right Atrial Pressure on Fractional Flow Reserve Measurements: Comparison of Fractional Flow Reserve and Myocardial Fractional Flow Reserve in 1,600 Coronary Stenoses 31
Platelet reactivity and coronary microvascular impairment after percutaneous revascularization in stable patients receiving clopidogrel or prasugrel 31
Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm. 30
ELEVATED MYOCARDIAL AND LYNFOHOCYTE BETA ARK1 LEVELS IN HUMAN HEART FAILURE 30
Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Study. 30
A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-Month follow-up results of the EXCELLA II study 30
Direct stenting 30
Long-term effect of molsidomine, a direct nitric oxide donor, as an add-on treatment, on endothelial dysfunction in patients with stable angina pectoris undergoing percutaneous coronary intervention: results of the MEDCOR trial 30
Optical coherence tomography imaging during percutaneous coronary intervention impacts physician decision-making: ILUMIEN I study 30
Left atrial volume computed by 3D rotational angiography best predicts atrial fibrillation recurrence after circumferential pulmonary vein isolation 30
Impact of genetic polymorphisms on platelet function and response to anti platelet drugs 30
Insulin Resistance the Hinge Between Hypertension and Type 2 Diabetes 30
Global Fractional Flow Reserve Value Predicts 5-Year Outcomes in Patients With Coronary Atherosclerosis But Without Ischemia 30
Role of the sympathetic nervous system in cardiac remodeling in hypertension 29
Tissue Doppler Imaging Predicts Recovery of Left Ventricular Function after Recanalization of an Occluded Coronary Artery 29
Alpha-adrenergic receptor blockade and hyperaemic response in patients with intermediate coronary stenoses 29
How would I treat? The invited expert's opinion 29
Continuum of Vasodilator Stress From Rest to Contrast Medium to Adenosine Hyperemia for Fractional Flow Reserve Assessment 29
Overview of the clinical trials on bioresorbable vascular scaffold 29
High platelet reactivity and periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention: A significant association beyond definitions 29
C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP 29
The role of fractional flow reserve to guide stent implantation. 28
Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses 28
Diabetes and coronary artery disease [Diabete e cardiopatia ischemica] 28
Effective radiation dose, time, and contrast medium to measure fractional flow reserve 28
Impact of platelet reactivity on 5-year clinical outcomes following percutaneous coronary intervention: a landmark analysis 28
Association of Improvement in Fractional Flow Reserve with Outcomes, Including Symptomatic Relief, after Percutaneous Coronary Intervention 28
Intracoronary ultrasound imaging: Universal praise, qualified adoption 27
Relation of Low Response to Clopidogrel Assessed With Point-of-Care Assay to Periprocedural Myonecrosis in Patients Undergoing Elective Coronary Stenting for Stable Angina Pectoris 27
Bioresorbable scaffolds for treatment of coronary bifurcation lesions: Critical appraisal and future perspectives 27
Relationship of asymmetric dimethylarginine (ADMA) with extent and functional severity of coronary atherosclerosis 27
Diagnostic Accuracy of Fast Computational Approaches to Derive Fractional Flow Reserve From Diagnostic Coronary Angiography: The International Multicenter FAVOR Pilot Study 27
Rotational atherectomy: you will never regret using it but you often regret not having used it! 27
Measurement of Hyperemic Pullback Pressure Gradients to Characterize Patterns of Coronary Atherosclerosis 27
The rationale for angiotensin receptor neprilysin inhibitors in a multi-targeted therapeutic approach to COVID-19 27
Exercise Training: The Holistic Approach in Cardiovascular Prevention 27
Iatrogenic atrial septal defect (iASD) after MitraClip system delivery: The key role of PaO2/FiO2 ratio in guiding post-procedural iASD closure. 26
Rationale and design of EXPLORE: A randomized, prospective, multicenter trial investigating the impact of recanalization of a chronic total occlusion on left ventricular function in patients after primary percutaneous coronary intervention for acute ST-elevation myocardial infarction 26
Effect of Phentolamine on the hyperemic response to Adenosine in patients with microvascular disease 26
Blood Pressure Levels at the Time of Percutaneous Coronary Revascularization and Risk of Coronary In-Stent Restenosis 26
Antegrade wire escalation for chronic total occlusions in coronary arteries: simple algorithms as a key to success 26
Totale 3.341
Categoria #
all - tutte 40.417
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.417


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020322 0 0 0 0 5 4 3 43 14 32 119 102
2020/2021326 17 5 17 13 21 31 14 61 33 8 47 59
2021/20221.296 6 23 9 0 15 31 18 43 237 46 92 776
2022/20231.878 336 79 33 148 235 211 10 192 329 198 76 31
2023/20241.244 51 193 149 86 54 133 40 123 19 27 248 121
2024/20251.080 450 498 8 38 86 0 0 0 0 0 0 0
Totale 7.267